Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
American Journal of Pharmaceutical Education|January 6, 2018
Engaging Pharmacy Students in Research Through Near-Peer TrainingBenjamin J Lee, Nathaniel J Rhodes, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2014
Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemesNathaniel J Rhodes, Shawn H MacVane, Joseph L Kuti, et al.
Pharmacotherapy|March 24, 2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumoniaMarc H Scheetz, Richard G Wunderink, Michael J Postelnick, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
An analysis of the accuracy of physician-entered indications on computerized antimicrobial ordersJean A Patel, John S Esterly, Marc H Scheetz, et al.
Pharmacotherapy|December 1, 2010
Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibilityMarc H Scheetz, Stephanie A Knechtel, Michael J Postelnick, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2021
The case for precision dosing: medical conservatism does not justify inactionMarc H Scheetz, Thomas P Lodise, Kevin J Downes, et al.
International Journal of Antimicrobial Agents|April 18, 2018
Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysisJ Nicholas O'Donnell, Nathaniel J Rhodes, Jenna Lopez, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2008
Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumptionMarc H Scheetz, Stephanie A Knechtel, Michael Malczynski, et al.
International Journal of Antimicrobial Agents|February 28, 2024
Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat modelJack Chang, Gwendolyn M Pais, Raymond Jubrail, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 5, 2016
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrationsJ Nicholas O'Donnell, Natarajan Venkatesan, Malav Manek, et al.
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
American Journal of Pharmaceutical Education|January 6, 2018
Engaging Pharmacy Students in Research Through Near-Peer TrainingBenjamin J Lee, Nathaniel J Rhodes, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2014
Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemesNathaniel J Rhodes, Shawn H MacVane, Joseph L Kuti, et al.
Pharmacotherapy|March 24, 2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumoniaMarc H Scheetz, Richard G Wunderink, Michael J Postelnick, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
An analysis of the accuracy of physician-entered indications on computerized antimicrobial ordersJean A Patel, John S Esterly, Marc H Scheetz, et al.
Pharmacotherapy|December 1, 2010
Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibilityMarc H Scheetz, Stephanie A Knechtel, Michael J Postelnick, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2021
The case for precision dosing: medical conservatism does not justify inactionMarc H Scheetz, Thomas P Lodise, Kevin J Downes, et al.
International Journal of Antimicrobial Agents|April 18, 2018
Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysisJ Nicholas O'Donnell, Nathaniel J Rhodes, Jenna Lopez, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2008
Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumptionMarc H Scheetz, Stephanie A Knechtel, Michael Malczynski, et al.
International Journal of Antimicrobial Agents|February 28, 2024
Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat modelJack Chang, Gwendolyn M Pais, Raymond Jubrail, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 5, 2016
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrationsJ Nicholas O'Donnell, Natarajan Venkatesan, Malav Manek, et al.
Pageof 23